A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
Clinical trial NCT06948448 · RECRUITING
Trial details
- NCT number
- NCT06948448
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-18
- Primary completion
- 2028-02-15
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.